Published in J Cell Biol on September 01, 1982
Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol (1989) 3.44
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes. J Cell Biol (1991) 1.42
Analysis of the factors that limit the ability of feeder cells to maintain the undifferentiated state of human embryonic stem cells. Stem Cells Dev (2009) 1.00
Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix. Am J Respir Cell Mol Biol (2006) 0.98
An unusual strain of human keratinocytes which do not stratify or undergo terminal differentiation in culture. J Cell Biol (1988) 0.93
The absence of Harvey ras mutations during development and progression of squamous cell carcinomas of the head and neck. Br J Cancer (1993) 0.91
Focal-adhesion-independent integrin-αv regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion. J Cell Sci (2015) 0.80
Modulation of type-IV procollagen and laminin production in A431 human squamous epidermoid carcinoma cells by 12-O-tetradecanoylphorbol-13-acetate (TPA) and epidermal growth factor (EGF). Arch Dermatol Res (1985) 0.78
Occurrence and control of sporadic proliferation in growth arrested Swiss 3T3 feeder cells. PLoS One (2015) 0.77
Epigenetic Regulation of Epidermal Stem Cell Biomarkers and Their Role in Wound Healing. Int J Mol Sci (2015) 0.75
Stem cell maintenance in a different niche. Clin Exp Reprod Med (2013) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem (1974) 113.22
Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry (1971) 66.90
Laminin--a glycoprotein from basement membranes. J Biol Chem (1979) 12.49
In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst (1973) 11.26
A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature (1975) 6.70
Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell (1980) 5.83
Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature (1977) 4.90
Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J (1979) 4.46
Role of laminin in the attachment of PAM 212 (epithelial) cells to basement membrane collagen. Cell (1980) 4.13
Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J Exp Med (1978) 3.95
Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci U S A (1979) 3.79
Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein. Lab Invest (1980) 3.64
Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol (1968) 3.20
Mechanisms of organogenetic tissue interaction. Natl Cancer Inst Monogr (1967) 3.01
Basal lamina scaffold-anatomy and significance for maintenance of orderly tissue structure. Am J Pathol (1974) 2.99
Permissive effect of the extracellular matrix on cell proliferation in vitro. Proc Natl Acad Sci U S A (1980) 2.71
Cyclic AMP in relation to proliferation of the epidermal cell: a new view. Cell (1978) 2.64
Dermo-epidermal separation with suction. Electron microscopic and histochemical study of initial events of blistering on human skin. J Invest Dermatol (1967) 2.41
Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell (1980) 2.39
A scanning electron microscope study of surface features of viral and spontaneous transformants of mouse Balb-3T3 cells. J Cell Biol (1973) 2.30
Heterogeneity in epidermal basal keratinocytes: morphological and functional correlations. Science (1982) 2.28
Human epidermal cell cultures: growth and differentiation in the absence of differentiation in the absence of dermal components or medium supplements. Proc Natl Acad Sci U S A (1979) 2.16
Biochemistry and metabolism of basement membranes. Int Rev Cytol (1979) 2.10
Studies on the biosynthesis of laminin by murine parietal endoderm cells. Eur J Biochem (1981) 1.99
Biosynthesis of two subunits of type IV procollagen and of other basement membrane proteins by a human tumor cell line. Eur J Biochem (1980) 1.90
Epidermal cells adhere preferentially to type IV (basement membrane) collagen. J Cell Biol (1979) 1.86
Localization of the collagenous component in skin basement membrane. J Invest Dermatol (1978) 1.86
Synthesis of collagen by mammalian cell lines of fibroblastic and nonfibroblastic origin. Proc Natl Acad Sci U S A (1965) 1.86
Differential response to growth factor by rat mammary epithelium plated on different collagen substrata in serum-free medium. Proc Natl Acad Sci U S A (1981) 1.69
Immediate visualization of proteins in dodecyl sulfate-polyacrylamide gels by prestaining with Remazol dyes. Anal Biochem (1972) 1.63
Antibodies to collagens and procollagens. Methods Enzymol (1982) 1.60
The epidermal-dermal junction. J Invest Dermatol (1975) 1.60
Optimized conditions for the growth of human epidermal cells in culture. J Invest Dermatol (1980) 1.57
Laminin and fibronectin in cell adhesion: enhanced adhesion of cells from regenerating liver to laminin. Proc Natl Acad Sci U S A (1981) 1.55
Characterization of pepsin fragments of basement membrane collagen obtained from a mouse tumor. Eur J Biochem (1979) 1.55
Substrate adhesion of rat hepatocytes: a comparison of laminin and fibronectin as attachment proteins. J Cell Biol (1981) 1.52
Secretion of collagen by corneal epithelium. I. Morphology of the collagenous products produced by isolated epithelia grown on frozen-killed lens. J Cell Biol (1973) 1.49
Fibronectin synthesis by epithelial crypt cells of rat small intestine. Proc Natl Acad Sci U S A (1978) 1.49
Formation and origin of basal lamina and anchoring fibrils in adult human skin. J Cell Biol (1971) 1.48
Clonal growth of human keratinocytes with small amounts of dialyzed serum. In Vitro (1980) 1.41
Synthesis of two collagen types by embryonic chick corneal epithelium in vitro. Proc Natl Acad Sci U S A (1977) 1.38
Type I collagen reduces the degradation of basal lamina proteoglycan by mammary epithelial cells. J Cell Biol (1981) 1.38
Malignant hemangioendotheliomas produced by subcutaneous inoculation of Balb/3T3 cells attached to glass beads. Science (1975) 1.36
Production of fibronectin by human epithelial cells in culture. Cancer Res (1979) 1.34
Growth and differentiation of human keratinocytes without a feeder layer or conditioned medium. In Vitro (1980) 1.33
Fluorescent antibodies and lectins stain intracellular structures in fixed cells treated with nonionic detergent. J Histochem Cytochem (1978) 1.30
A unique, pepsin-sensitive collagen synthesized by aortic endothelial cells in culture. Biochemistry (1980) 1.23
Migrating epidermis produces AB2 collagen and requires continual collagen synthesis for movement. Nature (1979) 1.22
Control of a cell surface major glycoprotein by epidermal growth factor. Science (1977) 1.21
Human glomerular visceral epithelial cells synthesize a basal lamina collagen in vitro. Proc Natl Acad Sci U S A (1979) 1.19
Fibronectin distribution in epithelial and associated tissues of the rat. Arch Dermatol Res (1979) 1.17
Extracellular matrix components synthesized by human amniotic epithelial cells in culture. Cell (1980) 1.12
Kinetics of processing of type I and type III procollagens in fibroblast cultures. Proc Natl Acad Sci U S A (1977) 1.11
Posttranslational modifications in the biosynthesis of type IV collagen by a human tumor cell line. Biochemistry (1981) 1.09
Expression of basement membrane zone antigens at the dermo-epibolic junction in organ cultures of human skin. J Invest Dermatol (1980) 1.06
Dexamethasone-induced accumulation of a fibronectin and collagen extracellular matrix in transformed human cells. Nature (1979) 1.06
The processing of procollagen in cultures of human and mouse fibroblasts. Arch Biochem Biophys (1976) 1.04
Extracellular matrix proteins characterize human tumor cell lines. Int J Cancer (1981) 1.00
Basal lamina glycoproteins laminin and type IV collagen are assembled into a fine-fibered matrix in cultures of a teratocarcinoma-derived endodermal cell line. Exp Cell Res (1982) 0.97
Chinese hamster lung cells synthesize and confine to the cellular domain a collagen composed solely of B chains. Proc Natl Acad Sci U S A (1980) 0.97
The effect of dexamethasone on formation of a fibronectin extracellular matrix by rat hepatocytes in vitro. Exp Cell Res (1980) 0.96
Biochemical characterization of collagens synthesized by intestinal epithelial cell cultures. J Biol Chem (1980) 0.90
Production of both interstitial and basement membrane procollagens by fibroblastic WI-38 cells from human embryonic lung. Biochem Biophys Res Commun (1980) 0.87
Collagen synthesis as a marker for cell type in mouse 3T3 lines. Cell (1977) 0.86
Production of fibronectin by normal and malignant human mammary epithelial cells. Cancer Res (1981) 0.84
Endo- and ectocervical human uterine epithelial cells distinguished by fibronectin production and keratinization in culture. Cancer Res (1982) 0.77
Basal lamina components in experimentally induced skin blisters. J Invest Dermatol (1981) 0.76
Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature (1983) 8.18
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med (2001) 7.78
Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A (1995) 7.11
Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci U S A (1983) 7.01
Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (1997) 6.37
Pre- and post-Golgi vacuoles operate in the transport of Semliki Forest virus membrane glycoproteins to the cell surface. Cell (1984) 5.60
Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies. Br Med J (1968) 5.54
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J (1996) 5.33
Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science (1998) 5.07
Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol (1999) 5.02
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J (2001) 4.70
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A (1999) 4.52
Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med (2001) 4.50
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A (1998) 4.48
Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J (1979) 4.46
Clinical applications of angiogenic growth factors and their inhibitors. Nat Med (1999) 4.26
Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis (1980) 4.10
Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J (1997) 4.07
Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol (1993) 3.96
Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J Exp Med (1978) 3.95
Interaction of soluble fibroblast surface antigen with fribrinogen and fibrin. J Exp Med (1975) 3.91
High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in malignant transformation. Biochim Biophys Acta (1978) 3.89
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J (2001) 3.88
Identification of nuclear proteins encoded by viral and cellular myc oncogenes. Nature (1984) 3.86
PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol (2000) 3.81
Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A (1998) 3.72
Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol (1994) 3.68
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet (2000) 3.66
A cellular oncogene (c-Ki-ras) is amplified, overexpressed, and located within karyotypic abnormalities in mouse adrenocortical tumour cells. Nature (1983) 3.56
Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture. Virology (1965) 3.50
Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res (2001) 3.38
Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus. Int J Cancer (1974) 3.24
Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol (1968) 3.20
FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J (1991) 3.19
Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science (1985) 3.17
The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J (1995) 3.16
Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med (1993) 3.14
VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol (1999) 3.09
Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol (1995) 3.06
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J (2001) 3.00
Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science (2001) 2.99
Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. J Virol (1967) 2.95
Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol (2001) 2.89
A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A (2001) 2.88
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem (1994) 2.87
Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet (1997) 2.86
Distribution of fibroblast surface antigen in the developing chick embryo. J Exp Med (1975) 2.85
Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn (1995) 2.83
VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development (1996) 2.82
Molecular cloning of the beta-subunit of human prolyl 4-hydroxylase. This subunit and protein disulphide isomerase are products of the same gene. EMBO J (1987) 2.79
Posttranslational enzymes in the biosynthesis of collagen: intracellular enzymes. Methods Enzymol (1982) 2.77
Induction of a basement membrane glycoprotein in embryonic kidney: possible role of laminin in morphogenesis. Proc Natl Acad Sci U S A (1980) 2.74
Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta (1973) 2.71
Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A (1996) 2.71
PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol (2001) 2.70
External fibronectin of cultured human fibroblasts is predominantly a matrix protein. J Cell Biol (1978) 2.70
Repression of cyclin D1: a novel function of MYC. Mol Cell Biol (1994) 2.67
Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc Natl Acad Sci U S A (1983) 2.66
Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res (2000) 2.64
Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res (2000) 2.63
Distribution of fibroblast surface antigen: association with fibrillar structures of normal cells and loss upon viral transformation. J Exp Med (1974) 2.62
Cytovillin, a microvillar Mr 75,000 protein. cDNA sequence, prokaryotic expression, and chromosomal localization. J Biol Chem (1989) 2.61
Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res (1998) 2.60
Hantaviruses: genome structure, expression and evolution. J Gen Virol (1996) 2.47
Oncogene amplification in tumor cells. Adv Cancer Res (1986) 2.44
Fibronectin is produced by human macrophages. J Exp Med (1980) 2.44
VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol (1997) 2.43
Dermo-epidermal separation with suction. Electron microscopic and histochemical study of initial events of blistering on human skin. J Invest Dermatol (1967) 2.41
Novel human serum protein from fibroblast plasma membrane. Nature (1974) 2.35
A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol (1992) 2.34
Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay. J Infect Dis (1980) 2.33
Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen. Proc Natl Acad Sci U S A (1978) 2.32
Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci U S A (1998) 2.32
Infectious poliovirus RNA: a sensitive method of assay. Virology (1965) 2.28
Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem (1998) 2.28
Appearance and distribution of collagens and laminin in the early mouse embryo. Dev Biol (1980) 2.27
VEGFs, receptors and angiogenesis. Semin Cancer Biol (1999) 2.25
Enhancement of infectivity of poliovirus RNA with diethylaminoethyl-dextran (DEAE-D). Arch Gesamte Virusforsch (1965) 2.25
Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol (2000) 2.24
Nonmuscle and muscle tropomyosin isoforms are expressed from a single gene by alternative RNA splicing and polyadenylation. Mol Cell Biol (1986) 2.20
Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell (1982) 2.20
Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci U S A (2001) 2.19
Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol (1979) 2.19
Dimeric character of fibronectin, a major cell surface-associated glycoprotein. Biochem Biophys Res Commun (1977) 2.18
The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity. EMBO J (1992) 2.16
Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest (1980) 2.16
VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J (2000) 2.06
Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol (2001) 2.05
Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNA. Neurology (1995) 2.05
ICAM-2 redistributed by ezrin as a target for killer cells. Nature (1996) 2.04
Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J Biol Chem (1998) 2.01
FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res (1992) 1.99
A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem (1998) 1.98
Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer (1999) 1.97
Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol (1988) 1.97
Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol (2001) 1.96